25C-NB3OMe

{{Short description|Chemical compound}}

{{Drugbox

| verifiedrevid =

| IUPAC_name = 2-(4-Chloro-2,5-dimethoxyphenyl)-N-[(3-methoxyphenyl)methyl]ethanamine

| image = 25C-NB3OMe.svg

| width = 200px

| tradename =

| pregnancy_category =

| routes_of_administration =

| bioavailability =

| metabolism =

| elimination_half-life =

| excretion =

| CAS_number_Ref = {{cascite|correct|??}}

| CAS_number = 1566571-34-3

| CAS_supplemental =

| UNII_Ref = {{fdacite|correct|FDA}}

| UNII = 6NH04YN8AH

| ATC_prefix = none

| PubChem = 118796502

| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}

| ChemSpiderID = 52085462

| C=18 | H=22 | Cl=1 | N=1 | O=3

| smiles = COC1=CC=CC(=C1)CNCCC2=CC(=C(C=C2OC)Cl)OC

| StdInChI = 1S/C18H22ClNO3/c1-21-15-6-4-5-13(9-15)12-20-8-7-14-10-18(23-3)16(19)11-17(14)22-2/h4-6,9-11,20H,7-8,12H2,1-3H3

| StdInChIKey = CSLNJUOCJZCEIR-UHFFFAOYSA-N

}}

25C-NB3OMe (2C-C-NB3OMe, NB3OMe-2C-C) is a derivative of the phenethylamine hallucinogen 2C-C, which acts as a highly potent partial agonist for the human 5-HT_2A receptor.https://bitnest.netfirms.com/external.php?id=%2501%253B5%25168%250F%2518%250DG%257F%255B18%2521UYHRO%2500JAsca%2515%255C{{Dead link|date=June 2020 |bot=InternetArchiveBot |fix-attempted=yes }}https://bitnest.netfirms.com/external.php?id=%2501%253B5%25168%250F%2518%250DG%257F%255B18%2521UYHZP%251CUTscc%250BWk{{Dead link|date=June 2020 |bot=InternetArchiveBot |fix-attempted=yes }}